Cargando…

OR33-03 Congenital Leptin Deficiency: Clinical Insights from the First Reported US Cases

Background: Congenital leptin deficiency (CLD) is a rare autosomal recessive form of monogenic obesity caused by loss-of-function mutations in the leptin gene. Targeted therapy is available in the form of recombinant human leptin (metreleptin). Previous case series have reported dramatic weight loss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torchen, Laura C, Hakamy, Beth, Gordon, Leo I, Marsh, Erica E, Yaseen, Nabeel R, Neff, Lisa M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Adipose Tissue, Appetite, and Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207930/ http://dx.doi.org/10.1210/jendso/bvaa046.1059

Ejemplares similares

RF12 | PSUN125 Lymphoma in Congenital Leptin Deficiency: Comorbidity or Adverse Effect?
por: Torchen, Laura, et al.
Publicado: (2022)

RF24 | PSUN127 Congenital Leptin Deficiency: Metabolic, Reproductive, and Psychological Impacts of Therapy
por: Torchen, Laura, et al.
Publicado: (2022)

FRI069 Treatment With Mibavademab, A Novel Leptin Receptor Agonist, Is Associated With Improvement In Weight And Associated Comorbidities In Congenital Leptin Deficiency
por: Ozsu, Elif, et al.
Publicado: (2023)

OR33-02 The Treatment of Partial Lipodystrophy in the Setting of Neutralizing Antibody Against Metreleptin with Leptin Receptor Agonist REGN4461
por: Akinci, Baris, et al.
Publicado: (2020)

OR04-03 Calcitonin Receptor Expressing Neurons in the PVH Regulate Feeding Behavior
por: Gonzalez, Ian Enrique, et al.
Publicado: (2020)

OR12-1 Leptin Is Transported across the Mouse Placenta
por: Park, Soyoung, et al.
Publicado: (2019)

SUN-096 Hypothalamic ATP Has a Crucial Role in the Pathogenesis of Leptin Resistance: A Potential Mechanism for the Amelioration of Leptin Resistance by Celastrol and Withaferin A
por: Ebihara, Chihiro, et al.
Publicado: (2019)

Leptin Decreases Energy Expenditure but Increases Thyroid Hormone in Patients With Lipodystrophy
por: Quaye, Emmanuel, et al.
Publicado: (2021)

LBSUN131 Leptin Level, BMI And Genetics In Early Onset Obesity
por: Xu, Xu, et al.
Publicado: (2022)

FRI039 Endothelial Dysfunction Is Associated With Adiponectin And Leptin In Adolescents With PCOS
por: Gavryutina, Irina, et al.
Publicado: (2023)

SAT-604 The Role of the Focal Adhesion Kinase Family in Leptin Receptor Signaling
por: Hadley, Colleen, et al.
Publicado: (2020)

PSUN100 What Determines Leptin Levels: Moving Beyond Fat Mass
por: Rosenberg, Drake, et al.
Publicado: (2022)

OR07-03 UCP1 Expression In Human Brown Adipose Tissue Is Inversely Associated With Cardiometabolic Risk Factors
por: Kwok, T'ng Choong, et al.
Publicado: (2023)

OR33-06 Potential Role of Mutations in TBX3 in Human Weight Regulation
por: Xu, Yanjun, et al.
Publicado: (2020)

OR33-05 Amino Acid Signature of Abdominal Obesity in the TwinsUK Cohort
por: Maltais-Payette, Ina, et al.
Publicado: (2020)

Severe Early-Onset Obesity in Three Adult Patients Harboring Inactivating Mutations of the Leptin Receptor Gene
por: Chaves, Carolina Marques, et al.
Publicado: (2021)

OR33-04 The Effect of Adiposity on the Fasting Serum Proteome in Normal Weight and Obese Men
por: Harshman, Stephanie Geris, et al.
Publicado: (2020)

Timing of Onset of Adverse Events With Setmelanotide, an MC4R Agonist, in Patients With Severe Obesity Due to LEPR or POMC Deficiency
por: Clément, Karine, et al.
Publicado: (2021)

SAT-595 Early Weight Gain Impact onto the Arcuate Leptin Receptor Expressing Neurons Activity During Development
por: Zampieri, Thais T, et al.
Publicado: (2020)

FRI057 Drug Concentrations And Dosing Considerations For Mibavademab, A Novel Leptin Receptor Agonist, In Individuals With Generalized Lipodystrophy
por: Mendell, Jeanne, et al.
Publicado: (2023)

FRI059 Long-term Follow-up On Partial Lipodystrophy Treated With Leptin Receptor Agonist Mibavademab(REGN4461)
por: Foss de Freitas, Maria Cristina, et al.
Publicado: (2023)

OR33-01 Liraglutide for Weight Management in Pubertal Adolescents with Obesity: A Randomized Controlled Trial
por: Kelly, Aaron S, et al.
Publicado: (2020)

OR33-07 ARNT2: A Potential Novel Candidate Gene for Monogenic Obesity in Humans
por: Thaker, Vidhu V, et al.
Publicado: (2020)

OR10-03 Murine Bimagrumab Co-administration With Incretin Agonists Results In Additive Efficacy And Superior Quality Weight Loss In The Mouse Diet-induced Obesity Model
por: Nguyen, Kevin, et al.
Publicado: (2023)

MON-596 Effects of Angiotensin Type 1 Receptor Blockers (ARBs) on the Expression and Secretion of Adiponectin and Leptin in Human White Adipocytes
por: Hattori, Naoki, et al.
Publicado: (2020)

FRI058 Treatment With Mibavademab, A Novel Leptin Receptor Agonist, Is Associated With Improvement In Metabolic Parameters In Individuals With Generalized Lipodystrophy
por: Olenchock, Ben, et al.
Publicado: (2023)

Serotonin as a Regulator of Leptin-Mediated Food Intake Control Within a Novel Neuronal Circuit Between the Hypothalamus and Raphe Nuclei
por: Sadek, Alia T, et al.
Publicado: (2021)

RF12 | PSUN105 Cord Blood Leptin and Childhood Adiposity Outcomes in the Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study
por: DeLacey, Sean, et al.
Publicado: (2022)

FRI031 A Novel Strategy To Detect Leptin Receptor (Lepr, fa) Mutation In Obesity And Diabetic Animal Model (Zucker Rats)
por: Xu, Xinyun, et al.
Publicado: (2023)

OR12-6 Deletion Of The Brain-Specific α And δ Isoforms Of SH2B1 Protects Against Diet-Induced Obesity In A Leptin-Independent Manner
por: Cote, Jessica, et al.
Publicado: (2019)

FRI008 Impact Of Sleep Fragmentation And Estradiol Suppression On Leptin, Ghrelin, Satiety And Hunger In Women: An Experimental Menopause Model To Understand Menopause-related Body Fat Gain
por: Rahman, Shadab A, et al.
Publicado: (2023)

OR01-5 Leptin Acts through Altering Energy Intake and Lipolysis to Reduce Body Weight but Has No Effect on Energy Expenditure, Physical Activity, and Sympathetic Nervous System in Humans
por: Chrysafi, Pavlina, et al.
Publicado: (2019)

MON-116 Liposuction for Lipedema (Persistent Fat) in the US Improves Quality of Life
por: Cobos, Leopoldo, et al.
Publicado: (2019)

OR10-5 Fructose Consumption and NAFLD in US Adult Population of NHANES 17-18
por: Kermah, Dulcie, et al.
Publicado: (2022)

ODP607 Long-term Efficacy of Setmelanotide in Patients With POMC or LEPR Deficiency Obesity
por: Clément, Karine, et al.
Publicado: (2022)

SAT659 Prevalence Of Multimorbidity Across Age Groups Among Us Adults With Overweight Or Obesity
por: Ezendu, Kyrian, et al.
Publicado: (2023)

SAT664 Obesity And Overweight Diagnosis, Physician Prescription And Patient Filling Of Anti-Obesity Medications In US
por: Ezendu, Kyrian, et al.
Publicado: (2023)

SAT660 Predictors Of Achieving Body Weight Reduction ≥20% With Tirzepatide In People With Overweight Or Obesity In SURMOUNT-1
por: Srinath, Reshmi, et al.
Publicado: (2023)

SAT658 Tirzepatide Reduces The Predicted Risk Of Developing Atherosclerotic Cardiovascular Disease: A Post-hoc Analysis Of The Surmount-1 Trial
por: Hankosky, Emily R, et al.
Publicado: (2023)

SUN-604 U.S. Prevalence & Mortality of Prader-Willi Syndrome: A Population-Based Study of Medical Claims
por: McCandless, Shawn E, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sup1t73ttugo0ae3j14k56uueq